Correlation Between Kiromic Biopharma and Palisade Bio
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Palisade Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Palisade Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Palisade Bio, you can compare the effects of market volatilities on Kiromic Biopharma and Palisade Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Palisade Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Palisade Bio.
Diversification Opportunities for Kiromic Biopharma and Palisade Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kiromic and Palisade is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Palisade Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palisade Bio and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Palisade Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palisade Bio has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Palisade Bio go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Palisade Bio
If you would invest 268.00 in Kiromic Biopharma on November 3, 2024 and sell it today you would earn a total of 0.00 from holding Kiromic Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Kiromic Biopharma vs. Palisade Bio
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Palisade Bio |
Kiromic Biopharma and Palisade Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Palisade Bio
The main advantage of trading using opposite Kiromic Biopharma and Palisade Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Palisade Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will offset losses from the drop in Palisade Bio's long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences | Palisade Bio vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |